Top

Clinical Reviews in Allergy & Immunology

Published in:

01-12-2018

Unmet Needs in IBD: the Case of Fatigue

Authors: Pieter Hindryckx, Debby Laukens, Ferdinando D’Amico, Silvio Danese

Published in: Clinical Reviews in Allergy & Immunology | Issue 3/2018

Abstract

Fatigue is a highly prevalent but relatively ignored problem in IBD patients. It is one of the most burdensome symptoms to the patient with an important impact on the quality of life. Therefore, fatigue is a highly relevant patient-reported outcome that should be included not only in disease activity measurement but also in the endpoints of clinical trials in IBD. However, most of the currently available scoring systems to quantify fatigue are not specifically designed for patients with IBD and none of them has undergone a complete validation process for IBD-related fatigue. Fatigue is more prevalent in patients with active disease and may improve or disappear when remission is reached. Far more complex is the persistence or onset of fatigue in quiescent IBD which presents in up to 40% of the patients. In this subgroup of patients, fatigue can be related to smoldering systemic inflammation, a poor sleep quality, anemia, nutritional deficiencies, or comorbidities. In most cases, however, no direct cause can be identified. The lack of knowledge on the mechanisms that drive fatigue in IBD hamper the development of specific drugs to treat the condition and only psychological support can be offered to the patient. Rodent models are indispensable to increase our understanding of the molecular pathways that lead to fatigue in chronic intestinal inflammation, and to develop novel therapies.

Ordas I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ (2012) Ulcerative colitis. Lancet (Lond, Engl) 380(9853):1606–1619. https://doi.org/10.1016/s0140-6736(12)60150-0 CrossRef

Baumgart DC, Sandborn WJ (2012) Crohn’s disease. Lancet (Lond, Engl) 380(9853):1590–1605. https://doi.org/10.1016/s0140-6736(12)60026-9 CrossRef

Williet N, Sarter H, Gower-Rousseau C, Adrianjafy C, Olympie A, Buisson A et al (2017) Patient-reported outcomes in a French nationwide survey of inflammatory bowel disease patients. J Crohns Colitis 11(2):165–174. https://doi.org/10.1093/ecco-jcc/jjw145 CrossRefPubMed

Farrell D, McCarthy G, Savage E (2016) Self-reported symptom burden in individuals with inflammatory bowel disease. J Crohns Colitis. 10(3):315–322. https://doi.org/10.1093/ecco-jcc/jjv218 CrossRefPubMed

Hashash JG, Ramos-Rivers C, Youk A, Chiu WK, Duff K, Regueiro M et al (2016) Quality of sleep and coexistent psychopathology have significant impact on fatigue burden in patients with inflammatory bowel disease. J Clin Gastroenterol. https://doi.org/10.1097/mcg.0000000000000729 CrossRefPubMed

van Langenberg DR, Gibson PR (2010) Systematic review: fatigue in inflammatory bowel disease. Aliment Pharmacol Ther 32(2):131–143. https://doi.org/10.1111/j.1365-2036.2010.04347.x CrossRefPubMed

Grimstad T, Norheim KB, Isaksen K, Leitao K, Hetta AK, Carlsen A et al (2015) Fatigue in newly diagnosed inflammatory bowel disease. J Crohns Colitis 9(9):725–730. https://doi.org/10.1093/ecco-jcc/jjv091 CrossRefPubMed

Opheim R, Fagermoen MS, Bernklev T, Jelsness-Jorgensen LP, Moum B (2014) Fatigue interference with daily living among patients with inflammatory bowel disease. Qual Life Res Int J Qual Life Asp Treat Care Rehab 23(2):707–717. https://doi.org/10.1007/s11136-013-0508-4 CrossRef

Romkens TE, van Vugt-van Pinxteren MW, Nagengast FM, van Oijen MG, de Jong DJ (2011) High prevalence of fatigue in inflammatory bowel disease: a case control study. J Crohns Colitis. 5(4):332–337. https://doi.org/10.1016/j.crohns.2011.02.008 CrossRefPubMed

10.

DeFilippis EM, Tabani S, Warren RU, Christos PJ, Bosworth BP, Scherl EJ (2016) Exercise and self-reported limitations in patients with inflammatory bowel disease. Dig Dis Sci 61(1):215–220. https://doi.org/10.1007/s10620-015-3832-4 CrossRefPubMed

11.

IsHak WW, Pan D, Steiner AJ, Feldman E, Mann A, Mirocha J et al (2017) Patient-reported outcomes of quality of life, functioning, and GI/psychiatric symptom severity in patients with inflammatory bowel disease (IBD). Inflamm Bowel Dis 23(5):798–803. https://doi.org/10.1097/mib.0000000000001060 CrossRefPubMed

12.

Holko P, Kawalec P, Mossakowska M, Pilc A (2016) Health-related quality of life impairment and indirect cost of Crohn’s disease: a self-report study in Poland. PLoS One 11(12):e0168586. https://doi.org/10.1371/journal.pone.0168586 CrossRefPubMedPubMedCentral

13.

Zand A, van Deen WK, Inserra EK, Hall L, Kane E, Centeno A et al (2015) Presenteeism in inflammatory bowel diseases: a hidden problem with significant economic impact. Inflamm Bowel Dis 21(7):1623–1630. https://doi.org/10.1097/mib.0000000000000399 CrossRefPubMed

14.

Dibley L, Bager P, Czuber-Dochan W, Farrell D, Jelsness-Jorgensen LP, Kemp K et al (2017) Identification of research priorities for inflammatory bowel disease nursing in Europe: a Nurses-European Crohn’s and Colitis Organisation Delphi Survey. J Crohns Colitis. 11(3):353–359. https://doi.org/10.1093/ecco-jcc/jjw164 CrossRefPubMed

15.

Hart AL, Lomer M, Verjee A, Kemp K, Faiz O, Daly A et al (2017) What are the top 10 research questions in the treatment of inflammatory bowel disease? A priority setting partnership with the James Lind Alliance. J Crohns Colitis. 11(2):204–211. https://doi.org/10.1093/ecco-jcc/jjw144 CrossRefPubMed

16.

Peyrin-Biroulet L, Panes J, Sandborn WJ, Vermeire S, Danese S, Feagan BG et al (2016) Defining disease severity in inflammatory bowel diseases: current and future directions. Clin Gastroenterol Hepatol 14(3):348–54.e17. https://doi.org/10.1016/j.cgh.2015.06.001 CrossRefPubMed

17.

Barsevick AM, Cleeland CS, Manning DC, O'Mara AM, Reeve BB, Scott JA et al (2010) ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manag 39(6):1086–1099. https://doi.org/10.1016/j.jpainsymman.2010.02.006 CrossRef

18.

Hjollund NH, Andersen JH, Bech P (2007) Assessment of fatigue in chronic disease: a bibliographic study of fatigue measurement scales. Health Qual Life Outcomes 5:12. https://doi.org/10.1186/1477-7525-5-12 CrossRefPubMedPubMedCentral

19.

Dittner AJ, Wessely SC, Brown RG (2004) The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res 56(2):157–170. https://doi.org/10.1016/S0022-3999(03)00371-4 CrossRefPubMed

20.

Czuber-Dochan W, Ream E, Norton C (2013) Review article: description and management of fatigue in inflammatory bowel disease. Aliment Pharmacol Ther 37(5):505–516. https://doi.org/10.1111/apt.12205 CrossRefPubMed

21.

Vogelaar L, van't Spijker A, van Tilburg AJ, Kuipers EJ, Timman R, van der Woude CJ (2013) Determinants of fatigue in Crohn’s disease patients. Eur J Gastroenterol Hepatol 25(2):246–251. https://doi.org/10.1097/MEG.0b013e32835aba83 CrossRefPubMed

22.

Vogelaar L, van't Spijker A, Timman R, van Tilburg AJP, Bac D, Vogelaar T et al (2014) Fatigue management in patients with IBD: a randomised controlled trial. Gut 63(6):911–918. https://doi.org/10.1136/gutjnl-2013-305191 CrossRefPubMed

23.

Norton C, Czuber-Dochan W, Bassett P, Berliner S, Bredin F, Darvell M et al (2015) Assessing fatigue in inflammatory bowel disease: comparison of three fatigue scales. Aliment Pharmacol Ther 42(2):203–211. https://doi.org/10.1111/apt.13255 CrossRefPubMed

24.

Brandse JF, Vos LM, Jansen J, Schakel T, Ponsioen CI, van den Brink GR et al (2015) Serum concentration of anti-TNF antibodies, adverse effects and quality of life in patients with inflammatory bowel disease in remission on maintenance treatment. J Crohns Colitis 9(11):973–981. https://doi.org/10.1093/ecco-jcc/jjv116 CrossRefPubMed

25.

Grimstad T, Norheim KB, Kvaloy JT, Isaksen K, Leitao K, Carlsen A et al (2016) Conventional treatment regimens for ulcerative colitis alleviate fatigue—an observational cohort study. Scand J Gastroenterol 51(10):1213–1219. https://doi.org/10.1080/00365521.2016.1195869 CrossRefPubMed

26.

Artom M, Czuber-Dochan W, Sturt J, Murrells T, Norton C (2017) The contribution of clinical and psychosocial factors to fatigue in 182 patients with inflammatory bowel disease: a cross-sectional study. Aliment Pharmacol Ther 45(3):403–416. https://doi.org/10.1111/apt.13870 CrossRefPubMed

27.

Vogelaar L, de Haar C, Aerts BR, Peppelenbosch MP, Timman R, Hanssen BE et al (2017) Fatigue in patients with inflammatory bowel disease is associated with distinct differences in immune parameters. Clin Exp Gastroenterol 10:83–90. https://doi.org/10.2147/ceg.s123942 CrossRefPubMedPubMedCentral

28.

Artom M, Czuber-Dochan W, Sturt J, Norton C (2017) Cognitive behavioural therapy for the management of inflammatory bowel disease-fatigue with a nested qualitative element: study protocol for a randomised controlled trial. Trials 18(1):213. https://doi.org/10.1186/s13063-017-1926-3 CrossRefPubMedPubMedCentral

29.

Huppertz-Hauss G, Hoivik ML, Jelsness-Jorgensen LP, Opheim R, Henriksen M, Hoie O et al (2017) Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: the IBSEN study. Scand J Gastroenterol 52(3):351–358. https://doi.org/10.1080/00365521.2016.1256425 CrossRefPubMed

30.

Tew GA, Carpenter R, Seed M, Anderson S, Langmead L, Fairhurst C et al (2017) Feasibility of high-intensity interval training and moderate-intensity continuous training in adults with inactive or mildly active Crohn’s disease: study protocol for a randomised controlled trial. Pilot Feasibility Stud 3:17. https://doi.org/10.1186/s40814-017-0133-z CrossRefPubMedPubMedCentral

31.

Smets EM, Garssen B, Bonke B, De Haes JC (1995) The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39(3):315–325CrossRefPubMed

32.

Belza BL, Henke CJ, Yelin EH, Epstein WV, Gilliss CL (1993) Correlates of fatigue in older adults with rheumatoid arthritis. Nurs Res 42(2):93–99CrossRefPubMed

33.

Vercoulen J, Albert M, Bleijenberg G (1999) De Checklist Individual Strength (CIS). Gedragstherapie 32:131–136

34.

Alberts M, Smets EM, Vercoulen JH, Garssen B, Bleijenberg G (1997) ‘Abbreviated fatigue questionnaire’: a practical tool in the classification of fatigue. Ned Tijdschr Geneeskd 141(31):1526–1530PubMed

35.

Czuber-Dochan W, Norton C, Bassett P, Berliner S, Bredin F, Darvell M et al (2014) Development and psychometric testing of inflammatory bowel disease fatigue (IBD-F) patient self-assessment scale. J Crohns Colitis. 8(11):1398–1406. https://doi.org/10.1016/j.crohns.2014.04.013 CrossRefPubMed

36.

Wolfe F (2004) Fatigue assessments in rheumatoid arthritis: comparative performance of visual analog scales and longer fatigue questionnaires in 7760 patients. J Rheumatol 31(10):1896–1902PubMed

37.

Irvine EJ, Feagan B, Rochon J, Archambault A, Fedorak RN, Groll A et al (1994) Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn’s Relapse Prevention Trial Study Group. Gastroenterology 106(2):287–296CrossRefPubMed

38.

Cheung WY, Garratt AM, Russell IT, Williams JG (2000) The UK IBDQ-a British version of the inflammatory bowel disease questionnaire. Development and validation. J Clin Epidemiol 53(3):297–306CrossRefPubMed

39.

Johnson JA, Coons SJ, Ergo A, Szava-Kovats G (1998) Valuation of EuroQOL (EQ-5D) health states in an adult US sample. PharmacoEconomics 13(4):421–433CrossRefPubMed

40.

Snaith RP, Zigmond AS (1986) The hospital anxiety and depression scale. Br Med J (Clin Res Ed) 292(6516):344CrossRef

41.

Lovibond PF, Lovibond SH (1995) The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther 33(3):335–343CrossRefPubMed

42.

Bager P, Befrits R, Wikman O, Lindgren S, Moum B, Hjortswang H et al (2012) Fatigue in out-patients with inflammatory bowel disease is common and multifactorial. Aliment Pharmacol Ther 35(1):133–141. https://doi.org/10.1111/j.1365-2036.2011.04914.x CrossRefPubMed

43.

Kappelman MD, Long MD, Martin C, DeWalt DA, Kinneer PM, Chen W et al (2014) Evaluation of the patient-reported outcomes measurement information system in a large cohort of patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 12(8):1315–23.e2. https://doi.org/10.1016/j.cgh.2013.10.019 CrossRefPubMed

44.

Graff LA, Clara I, Walker JR, Lix L, Carr R, Miller N et al (2013) Changes in fatigue over 2 years are associated with activity of inflammatory bowel disease and psychological factors. Clin Gastroenterol Hepatol 11(9):1140–1146. https://doi.org/10.1016/j.cgh.2013.03.031 CrossRefPubMed

45.

Yoo S, Jung YS, Park JH, Kim HJ, Cho YK, Sohn CI et al (2014) Fatigue severity and factors associated with high fatigue levels in Korean patients with inflammatory bowel disease. Gut Liver 8(2):148–153. https://doi.org/10.5009/gnl.2014.8.2.148 CrossRefPubMed

46.

Dantzer R (2009) Cytokine, sickness behavior, and depression. Immunol Allergy Clin N Am 29(2):247–264. https://doi.org/10.1016/j.iac.2009.02.002 CrossRef

47.

Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9(1):46–56. https://doi.org/10.1038/nrn2297 CrossRefPubMedPubMedCentral

48.

Abautret-Daly A, Dempsey E, Parra-Blanco A, Medina C, Harkin A (2017) Gut-brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease. Acta Neuropsychiatr:1–22. https://doi.org/10.1017/neu.2017.3 CrossRefPubMed

49.

Louati K, Berenbaum F (2015) Fatigue in chronic inflammation—a link to pain pathways. Arthritis Res Ther 17:254. https://doi.org/10.1186/s13075-015-0784-1 CrossRefPubMedPubMedCentral

50.

Jelsness-Jorgensen LP, Bernklev T, Henriksen M, Torp R, Moum BA (2011) Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls. Inflamm Bowel Dis 17(7):1564–1572. https://doi.org/10.1002/ibd.21530 CrossRefPubMed

51.

Goldenberg BA, Graff LA, Clara I, Zarychanski R, Walker JR, Carr R et al (2013) Is iron deficiency in the absence of anemia associated with fatigue in inflammatory bowel disease? Am J Gastroenterol 108(9):1392–1397. https://doi.org/10.1038/ajg.2013.14 CrossRefPubMed

52.

Cekic C, Ipek S, Aslan F, Akpinar Z, Arabul M, Topal F et al (2015) The effect of intravenous iron treatment on quality of life in inflammatory bowel disease patients with nonanemic iron deficiency. Gastroenterol Res Pract 2015:582163. https://doi.org/10.1155/2015/582163 CrossRefPubMedPubMedCentral

53.

Eliadou E, Kini G, Huang J, Champion A, Inns SJ (2017) Intravenous iron replacement improves quality of life in hypoferritinemic inflammatory bowel disease patients with and without anemia. Dig Dis (Basel, Switz). https://doi.org/10.1159/000468145 CrossRefPubMed

54.

Maes M, Mihaylova I, De Ruyter M (2006) Lower serum zinc in chronic fatigue syndrome (CFS): relationships to immune dysfunctions and relevance for the oxidative stress status in CFS. J Affect Disord 90(2–3):141–147. https://doi.org/10.1016/j.jad.2005.11.002 CrossRefPubMed

55.

Jacobson W, Saich T, Borysiewicz LK, Behan WM, Behan PO, Wreghitt TG (1993) Serum folate and chronic fatigue syndrome. Neurology 43(12):2645–2647CrossRefPubMed

56.

Huijts M, Duits A, Staals J, van Oostenbrugge RJ (2012) Association of vitamin B12 deficiency with fatigue and depression after lacunar stroke. PLoS One 7(1):e30519. https://doi.org/10.1371/journal.pone.0030519 CrossRefPubMedPubMedCentral

57.

Han B, Wu X, Guo Y (2017) Improvement of fatigue after vitamin D supplementation in kidney transplant recipients. Medicine 96(21):e6918. https://doi.org/10.1097/md.0000000000006918 CrossRefPubMedPubMedCentral

58.

Minderhoud IM, Oldenburg B, van Dam PS, van Berge Henegouwen GP (2003) High prevalence of fatigue in quiescent inflammatory bowel disease is not related to adrenocortical insufficiency. Am J Gastroenterol 98(5):1088–1093. https://doi.org/10.1111/j.1572-0241.2003.07414.x CrossRefPubMed

59.

Shizuma T (2016) Concomitant thyroid disorders and inflammatory bowel disease: a literature review. Biomed Res Int 2016:5187061. https://doi.org/10.1155/2016/5187061 CrossRefPubMedPubMedCentral

60.

Minderhoud IM, Samsom M, Oldenburg B (2007) Crohn’s disease, fatigue, and infliximab: is there a role for cytokines in the pathogenesis of fatigue? World J Gastroenterol 13(14):2089–2093CrossRefPubMedPubMedCentral

61.

Loftus EV, Feagan BG, Colombel JF, Rubin DT, Wu EQ, Yu AP et al (2008) Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn’s disease: patient-reported outcomes of the CHARM trial. Am J Gastroenterol 103(12):3132–3141. https://doi.org/10.1111/j.1572-0241.2008.02175.x CrossRefPubMed

62.

Jelsness-Jorgensen LP, Bernklev T, Henriksen M, Torp R, Moum BA (2011) Chronic fatigue is associated with impaired health-related quality of life in inflammatory bowel disease. Aliment Pharmacol Ther 33(1):106–114. https://doi.org/10.1111/j.1365-2036.2010.04498.x CrossRefPubMed

63.

Lee TW, Iser JH, Sparrow MP, Newnham ED, Headon BJ, Gibson PR (2009) Thiopurines, a previously unrecognised cause for fatigue in patients with inflammatory bowel disease. J Crohns Colitis. 3(3):196–199. https://doi.org/10.1016/j.crohns.2009.03.004 CrossRefPubMed

64.

van Langenberg DR, Gibson PR (2014) Factors associated with physical and cognitive fatigue in patients with Crohn’s disease: a cross-sectional and longitudinal study. Inflamm Bowel Dis 20(1):115–125. https://doi.org/10.1097/01.mib.0000437614.91258.70 CrossRefPubMed

65.

Graff LA, Vincent N, Walker JR, Clara I, Carr R, Ediger J et al (2011) A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflamm Bowel Dis 17(9):1882–1889. https://doi.org/10.1002/ibd.21580 CrossRefPubMed

66.

Opheim R, Fagermoen MS, Jelsness-Jorgensen LP, Bernklev T, Moum B (2014) Sense of coherence in patients with inflammatory bowel disease. Gastroenterol Res Pract 2014:989038. https://doi.org/10.1155/2014/989038 CrossRefPubMedPubMedCentral

67.

Banovic I, Gilibert D, Jebrane A, Cosnes J (2012) Personality and fatigue perception in a sample of IBD outpatients in remission: a preliminary study. J Crohns Colitis. 6(5):571–577. https://doi.org/10.1016/j.crohns.2011.11.006 CrossRefPubMed

68.

Harrington ME (2012) Neurobiological studies of fatigue. Prog Neurobiol 99(2):93–105. https://doi.org/10.1016/j.pneurobio.2012.07.004 CrossRefPubMedPubMedCentral

69.

Sorge RE, Martin LJ, Isbester KA, Sotocinal SG, Rosen S, Tuttle AH et al (2014) Olfactory exposure to males, including men, causes stress and related analgesia in rodents. Nat Methods 11(6):629–632. https://doi.org/10.1038/nmeth.2935 CrossRefPubMed

70.

Ray MA, Trammell RA, Verhulst S, Ran S, Toth LA (2011) Development of a mouse model for assessing fatigue during chemotherapy. Comp Med 61(2):119–130PubMedPubMedCentral

71.

Zombeck JA, Fey EG, Lyng GD, Sonis ST (2013) A clinically translatable mouse model for chemotherapy-related fatigue. Comp Med. 63(6):491–497PubMedPubMedCentral

72.

Can A, Dao DT, Arad M, Terrillion CE, Piantadosi SC, Gould TD (2012) The mouse forced swim test. J Vis Exp 59:e3638. https://doi.org/10.3791/3638 CrossRef

73.

Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I (1999) Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology 147(2):162–167CrossRefPubMed

74.

Kulesskaya N, Voikar V (2014) Assessment of mouse anxiety-like behavior in the light-dark box and open-field arena: role of equipment and procedure. Physiol Behav 133:30–38. https://doi.org/10.1016/j.physbeh.2014.05.006 CrossRefPubMed

75.

Strober W (2008) Why study animal models of IBD? Inflamm Bowel Dis 14(Suppl 2):S129–S131. https://doi.org/10.1002/ibd.20667 CrossRefPubMed

76.

Cramp F, Hewlett S, Almeida C, Kirwan JR, Choy EH, Chalder T, Pollock J, Christensen R (2013) Non-pharmacological interventions for fatigue in rheumatoid arthritis. Cochrane Database Syst Rev (8):CD008322. https://doi.org/10.1002/14651858.CD008322.pub2

77.

Loudon CP, Corroll V, Butcher J, Rawsthorne P, Bernstein CN (1999) The effects of physical exercise on patients with Crohn’s disease. Am J Gastroenterol 94(3):697–703. https://doi.org/10.1111/j.1572-0241.1999.00939.x CrossRefPubMed

78.

Vogelaar L, van den Berg-Emons R, Bussmann H, Rozenberg R, Timman R, van der Woude CJ (2015) Physical fitness and physical activity in fatigued and non-fatigued inflammatory bowel disease patients. Scand J Gastroenterol 50(11):1357–1367. https://doi.org/10.3109/00365521.2015.1046135 CrossRefPubMed

79.

Nathan I, Norton C, Czuber-Dochan W, Forbes A (2013) Exercise in individuals with inflammatory bowel disease. Gastroenterol Nurs 36(6):437–442. https://doi.org/10.1097/sga.0000000000000005 CrossRefPubMed

80.

Tew GA, Jones K, Mikocka-Walus A (2016) Physical activity habits, limitations, and predictors in people with inflammatory bowel disease: a large cross-sectional online survey. Inflamm Bowel Dis 22(12):2933–2942. https://doi.org/10.1097/mib.0000000000000962 CrossRefPubMed

81.

McCombie AM, Mulder RT, Gearry RB (2013) Psychotherapy for inflammatory bowel disease: a review and update. J Crohns Colitis. 7(12):935–949. https://doi.org/10.1016/j.crohns.2013.02.004 CrossRefPubMed

82.

Vogelaar L, van't Spijker A, Timman R, van Tilburg AJ, Bac D, Vogelaar T et al (2014) Fatigue management in patients with IBD: a randomised controlled trial. Gut 63(6):911–918. https://doi.org/10.1136/gutjnl-2013-305191 CrossRefPubMed

83.

Garcia-Vega E, Fernandez-Rodriguez C (2004) A stress management programme for Crohn’s disease. Behav Res Ther 42(4):367–383. https://doi.org/10.1016/s0005-7967(03)00146-3 CrossRefPubMed

Title: Unmet Needs in IBD: the Case of Fatigue
Authors: Pieter Hindryckx
Debby Laukens
Ferdinando D’Amico
Silvio Danese
Publication date: 01-12-2018
Publisher: Springer US
Published in: Clinical Reviews in Allergy & Immunology / Issue 3/2018
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI: https://doi.org/10.1007/s12016-017-8641-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2018

The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis

Autoimmunity in 2017

Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs

Unmet Needs in the Field of Psoriasis: Pathogenesis and Treatment

Unmet Needs in the Pathogenesis and Treatment of Systemic Lupus Erythematosus

Unmet Needs in Axial Spondyloarthritis

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage